PARADOXIC EFFECT OF MULTIPLE MILD COAGULATION-FACTOR DEFICIENCIES ON THE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME

Citation
Er. Burns et al., PARADOXIC EFFECT OF MULTIPLE MILD COAGULATION-FACTOR DEFICIENCIES ON THE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME, American journal of clinical pathology, 100(2), 1993, pp. 94-98
Citations number
20
Categorie Soggetti
Pathology
ISSN journal
00029173
Volume
100
Issue
2
Year of publication
1993
Pages
94 - 98
Database
ISI
SICI code
0002-9173(1993)100:2<94:PEOMMC>2.0.ZU;2-Z
Abstract
Single coagulation factor deficiencies predictably prolong the prothro mbin time (PT) and activated partial thromboplastin time (APTT) at lev els below 35% of normal activity. Acquired coagulopathies generally ar e characterized by multiple coagulation factor deficiencies. The effec t was studied of such combined deficiencies on the PT/APTT using plasm a from patients congenitally deficient in specific factors and pooled normal plasma. The PT begins to lengthen when individual factor levels fall below 25%. The APTT becomes prolonged when the levels of Factor V fall below 45%; the levels of Factors II and XI fall below 40%; and the levels of Factors I, V, VII, VIII, IX, and XII fall below 25% of n ormal. When plasma samples containing 50% activity of a single factor and 100% of all other factors were prepared by mixing the congenitally deficient plasma samples with the normal pool, the resulting mixtures had normal PT and APTT values. However, when two of these 50% factor- deficient plasmas were combined so that the mixture contained 75% acti vity of two coagulation factors and 100% of all other factors, the res ulting PT and APTT were prolonged over the clotting times of either 50 % factor-deficient plasma. Similar findings were obtained in patients with mild factor reductions caused by warfarin treatment. These data i ndicate that prolongations of the PF and APTT in disorders of coagulat ion affecting multiple factors represent less of a reduction in factor levels than is generally appreciated. This may explain the poor clini cal correlation between abnormalities in these test results and clinic al bleeding in acquired disorders of hemostasis.